{"filing":{"accession_number":"0001575872-26-000530","cik":"0001135951","ticker":"RDY","company_name":"DR REDDYS LABORATORIES LTD","form":"6-K","filing_date":"2026-07-23","report_date":null,"primary_document":"rdy0929_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1135951/000157587226000530/rdy0929_6k.htm"},"events":[{"id":19961,"run_id":17970,"accession_number":"0001575872-26-000530","anchor_item_number":"EX-99.1","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This exhibit discloses the outcome and voting results of Dr. Reddy's 42nd Annual General Meeting held on July 23, 2026, including the Scrutinizer's Report on remote e-voting and e-voting during the AGM, and agenda-wise voting details. Seven resolutions were voted on and declared passed by requisite majority, including adoption of audited financial statements, declaration of dividend, director re-appointments and appointments, auditor appointment, and cost auditor remuneration ratification. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent.","company_name":"DR REDDYS LABORATORIES LTD","ticker":"RDY","filing_date":"2026-07-23","form":"6-K","submitted_at":null,"items":[{"id":19196,"accession_number":"0001575872-26-000530","item_number":"EX-99.1","item_title":"rdy0929_ex99-1.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This exhibit discloses the outcome and voting results of Dr. Reddy's 42nd Annual General Meeting held on July 23, 2026, including the Scrutinizer's Report on remote e-voting and e-voting during the AGM, and agenda-wise voting details. Seven resolutions were voted on and declared passed by requisite majority, including adoption of audited financial statements, declaration of dividend, director re-appointments and appointments, auditor appointment, and cost auditor remuneration ratification. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-23T18:32:39.672615+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":19196,"accession_number":"0001575872-26-000530","item_number":"EX-99.1","item_title":"rdy0929_ex99-1.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This exhibit discloses the outcome and voting results of Dr. Reddy's 42nd Annual General Meeting held on July 23, 2026, including the Scrutinizer's Report on remote e-voting and e-voting during the AGM, and agenda-wise voting details. Seven resolutions were voted on and declared passed by requisite majority, including adoption of audited financial statements, declaration of dividend, director re-appointments and appointments, auditor appointment, and cost auditor remuneration ratification. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-23T18:32:39.672615+00:00","company_name":"DR REDDYS LABORATORIES LTD","ticker":"RDY","filing_date":"2026-07-23"}]}